Cargando…

Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients

We would like to comment on the recently published article titled: “Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients” by Ricci et al. The authors grouped the patients into two groups according to the vitamin D levels measured at the time of admission into the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohia, Prateek, Kapur, Shweta, Patel, Pragnesh, Seyoum, Berhane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032551/
https://www.ncbi.nlm.nih.gov/pubmed/33832495
http://dx.doi.org/10.1186/s12931-021-01703-1
_version_ 1783676231155187712
author Lohia, Prateek
Kapur, Shweta
Patel, Pragnesh
Seyoum, Berhane
author_facet Lohia, Prateek
Kapur, Shweta
Patel, Pragnesh
Seyoum, Berhane
author_sort Lohia, Prateek
collection PubMed
description We would like to comment on the recently published article titled: “Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients” by Ricci et al. The authors grouped the patients into two groups according to the vitamin D levels measured at the time of admission into the hospital and reported that lower vitamin D levels are associated with elevated D-dimer and IL-6 levels, low CD4/CD8 ratio and compromised clinical findings with elevated LIPI and SOFA scores. However, review of recent literature shows this association to be debatable. The 25-hydroxyvitamin D levels in the initial phase of critical illness have been reported to drop rapidly and hence consideration of the time of measurement from symptom onset would have enhanced the clinical relevance of these findings. Inferred association between vitamin D levels and disease severity based on SOFA score in COVID-19 patients, needs to be further explored in the light of the recent literature which casts doubt on using SOFA score at admission to predict mortality in COVID-19.
format Online
Article
Text
id pubmed-8032551
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80325512021-04-09 Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients Lohia, Prateek Kapur, Shweta Patel, Pragnesh Seyoum, Berhane Respir Res Letter to the Editor We would like to comment on the recently published article titled: “Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients” by Ricci et al. The authors grouped the patients into two groups according to the vitamin D levels measured at the time of admission into the hospital and reported that lower vitamin D levels are associated with elevated D-dimer and IL-6 levels, low CD4/CD8 ratio and compromised clinical findings with elevated LIPI and SOFA scores. However, review of recent literature shows this association to be debatable. The 25-hydroxyvitamin D levels in the initial phase of critical illness have been reported to drop rapidly and hence consideration of the time of measurement from symptom onset would have enhanced the clinical relevance of these findings. Inferred association between vitamin D levels and disease severity based on SOFA score in COVID-19 patients, needs to be further explored in the light of the recent literature which casts doubt on using SOFA score at admission to predict mortality in COVID-19. BioMed Central 2021-04-09 2021 /pmc/articles/PMC8032551/ /pubmed/33832495 http://dx.doi.org/10.1186/s12931-021-01703-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Lohia, Prateek
Kapur, Shweta
Patel, Pragnesh
Seyoum, Berhane
Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients
title Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients
title_full Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients
title_fullStr Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients
title_full_unstemmed Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients
title_short Letter to the editor: Vitamin D levels in acute illness and clinical severity in COVID-19 patients
title_sort letter to the editor: vitamin d levels in acute illness and clinical severity in covid-19 patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032551/
https://www.ncbi.nlm.nih.gov/pubmed/33832495
http://dx.doi.org/10.1186/s12931-021-01703-1
work_keys_str_mv AT lohiaprateek lettertotheeditorvitamindlevelsinacuteillnessandclinicalseverityincovid19patients
AT kapurshweta lettertotheeditorvitamindlevelsinacuteillnessandclinicalseverityincovid19patients
AT patelpragnesh lettertotheeditorvitamindlevelsinacuteillnessandclinicalseverityincovid19patients
AT seyoumberhane lettertotheeditorvitamindlevelsinacuteillnessandclinicalseverityincovid19patients